Chlorogenic Acid as a Modulator of Adipose Tissue Function and Metabolic Homeostasis: Evidence from Preclinical Studies. (PubMed, Nutrients) - Jul 29, 2026 - "Complementary in vivo studies in diet-induced obesity and diabetes models reveal that CGA reduces body weight gain, adiposity, adipocyte size and hepatic steatosis, improves lipid profiles, glucose tolerance and insulin sensitivity, and exerts anti-inflammatory and antioxidant effects in metabolic tissues. Collectively, current preclinical evidence supports CGA as a multifaceted modulator of adipose tissue function and whole-body metabolic homeostasis; however, rigorously designed, long-term clinical trials are required to establish its efficacy and safety in humans."
Journal • Preclinical • Review • Cardiovascular • Diabetes • Dyslipidemia • Genetic Disorders • Inflammation • Metabolic Disorders • Obesity • FASN • PPARG
|
|
Arshpreet Sehra; Evangelia Tsiani
|